Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2009

Open Access 01-02-2009 | Concise Article

Can Escherichia coli be used as an indicator organism for transmission events in hospitals?

Authors: P. J. van den Broek, A. T. Bernards, T. J. K. van der Reijden, B. van Strijen, L. Dijkshoorn

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2009

Login to get access

Abstract

Can Escherichia coli be used as an indicator organism for transmission events in hospitals? Perineal and pharyngeal swabs were obtained from patients admitted to a medical or surgical intensive care unit within 24 h of admission and then twice per week. Escherichia coli isolates were typed by random amplification of polymorphic DNA (RAPD) and amplified fragment length polymorphism (AFLP) typing. Based on the typing results, transmission rates for RAPD and AFLP typing were 8.5 and 6.6 per 100 patient-days. Requiring in addition to similarity in genotype parity in time and place for a transmission event, the incidence dropped to 3.8 (RAPD) and 1.7 (AFLP) per 100 patient-days. The two typing methods not only differed with respect to numbers of transmissions identified, but also to individuals involved in transmissions. This study identified a number of problems regarding the use of Escherichia coli as indicator organism for transmission events. The use of Escherichia coli for this purpose cannot be recommended at the moment.
Literature
1.
go back to reference Garner JS, The Hospital Infection Control Practices Advisory Committee (1996) Guidelines for isolation precautions in hospitals. I. Evolution of isolation practices. II. Recommendations for isolation precautions in hospitals. Am J Infect Control 24:24–52PubMedCrossRef Garner JS, The Hospital Infection Control Practices Advisory Committee (1996) Guidelines for isolation precautions in hospitals. I. Evolution of isolation practices. II. Recommendations for isolation precautions in hospitals. Am J Infect Control 24:24–52PubMedCrossRef
2.
go back to reference Vogel L, van Oorschot E, Maas HME, Minderhoud B, Dijkshoorn L (2000) Epidemiologic typing of Escherichia coli using RAPD analysis, ribotyping and serotyping. Clin Microbiol Infect 6:82–87PubMedCrossRef Vogel L, van Oorschot E, Maas HME, Minderhoud B, Dijkshoorn L (2000) Epidemiologic typing of Escherichia coli using RAPD analysis, ribotyping and serotyping. Clin Microbiol Infect 6:82–87PubMedCrossRef
3.
go back to reference Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, Dijkshoorn L (2001) Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 51:1891–1899PubMed Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, Dijkshoorn L (2001) Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 51:1891–1899PubMed
4.
go back to reference Hunter PR, Gaston MA (1988) Numerical index of the discriminatory ability of typing systems: an application of Simpson’s index of diversity. J Clin Microbiol 26:2465–2466PubMed Hunter PR, Gaston MA (1988) Numerical index of the discriminatory ability of typing systems: an application of Simpson’s index of diversity. J Clin Microbiol 26:2465–2466PubMed
5.
go back to reference Grundmann H, Bärwolf S, Tami A et al (2005) How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med 33:946–951PubMedCrossRef Grundmann H, Bärwolf S, Tami A et al (2005) How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med 33:946–951PubMedCrossRef
6.
go back to reference Eckmanns T, Schwab F, Bessert J et al (2006) Hand rub consumption and hand hygiene compliance are not indicators of pathogen transmission in intensive care units. J Hosp Infect 63:406–411PubMedCrossRef Eckmanns T, Schwab F, Bessert J et al (2006) Hand rub consumption and hand hygiene compliance are not indicators of pathogen transmission in intensive care units. J Hosp Infect 63:406–411PubMedCrossRef
7.
go back to reference Chetchotisakd P, Phelps CL, Hartstein AI (1994) Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units. Clin Infect Dis 18:929–937PubMed Chetchotisakd P, Phelps CL, Hartstein AI (1994) Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units. Clin Infect Dis 18:929–937PubMed
8.
go back to reference Weist K, Pollege K, Schulz I, Rüden H, Gastmeier P (2002) How many nosocomial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit. Infect Control Hosp Epidemiol 23:127–132PubMedCrossRef Weist K, Pollege K, Schulz I, Rüden H, Gastmeier P (2002) How many nosocomial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit. Infect Control Hosp Epidemiol 23:127–132PubMedCrossRef
Metadata
Title
Can Escherichia coli be used as an indicator organism for transmission events in hospitals?
Authors
P. J. van den Broek
A. T. Bernards
T. J. K. van der Reijden
B. van Strijen
L. Dijkshoorn
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0597-0

Other articles of this Issue 2/2009

European Journal of Clinical Microbiology & Infectious Diseases 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.